Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Hormone replacement therapy for cognitive function in postmenopausal women.

Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003122. doi: 10.1002/14651858.CD003122.pub2. Review.

PMID:
18254016
2.

Hormone replacement therapy for cognitive function in postmenopausal women.

Hogervorst E, Yaffe K, Richards M, Huppert F.

Cochrane Database Syst Rev. 2002;(3):CD003122. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD003122.

PMID:
12137675
3.

Hormone replacement therapy to maintain cognitive function in women with dementia.

Hogervorst E, Yaffe K, Richards M, Huppert F.

Cochrane Database Syst Rev. 2002;(3):CD003799. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD003799.

PMID:
12137718
4.

Hormone replacement therapy to maintain cognitive function in women with dementia.

Hogervorst E, Yaffe K, Richards M, Huppert FA.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003799. doi: 10.1002/14651858.CD003799.pub2. Review.

PMID:
19160224
5.

Long-term hormone therapy for perimenopausal and postmenopausal women.

Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J.

Cochrane Database Syst Rev. 2017 Jan 17;1:CD004143. doi: 10.1002/14651858.CD004143.pub5. Review.

PMID:
28093732
6.

Long term hormone therapy for perimenopausal and postmenopausal women.

Marjoribanks J, Farquhar C, Roberts H, Lethaby A.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004143. doi: 10.1002/14651858.CD004143.pub4. Review. Update in: Cochrane Database Syst Rev. 2017 Jan 17;1:CD004143.

PMID:
22786488
7.

Hormone therapy for sexual function in perimenopausal and postmenopausal women.

Nastri CO, Lara LA, Ferriani RA, Rosa-E-Silva AC, Figueiredo JB, Martins WP.

Cochrane Database Syst Rev. 2013 Jun 5;(6):CD009672. doi: 10.1002/14651858.CD009672.pub2. Review.

PMID:
23737033
8.

Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.

Norman RJ, Flight IH, Rees MC.

Cochrane Database Syst Rev. 2000;(2):CD001018. Review.

PMID:
10796730
9.

Dehydroepiandrosterone for women in the peri- or postmenopausal phase.

Scheffers CS, Armstrong S, Cantineau AE, Farquhar C, Jordan V.

Cochrane Database Syst Rev. 2015 Jan 22;1:CD011066. doi: 10.1002/14651858.CD011066.pub2. Review.

PMID:
25879093
10.

Hormone therapy for preventing cardiovascular disease in post-menopausal women.

Boardman HM, Hartley L, Eisinga A, Main C, Roqué i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B.

Cochrane Database Syst Rev. 2015 Mar 10;(3):CD002229. doi: 10.1002/14651858.CD002229.pub4. Review.

PMID:
25754617
11.

Short-term and long-term effects of tibolone in postmenopausal women.

Formoso G, Perrone E, Maltoni S, Balduzzi S, Wilkinson J, Basevi V, Marata AM, Magrini N, D'Amico R, Bassi C, Maestri E.

Cochrane Database Syst Rev. 2016 Oct 12;10:CD008536. Review.

PMID:
27733017
12.

1998 Curt P. Richter Award. The effect of hormone replacement therapy on cognitive function in elderly women.

Hogervorst E, Boshuisen M, Riedel W, Willeken C, Jolles J.

Psychoneuroendocrinology. 1999 Jan;24(1):43-68.

PMID:
10098219
13.

Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.

Lethaby A, Suckling J, Barlow D, Farquhar CM, Jepson RG, Roberts H.

Cochrane Database Syst Rev. 2004;(3):CD000402. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD000402.

PMID:
15266429
14.

Folic acid with or without vitamin B12 for cognition and dementia.

Malouf M, Grimley EJ, Areosa SA.

Cochrane Database Syst Rev. 2003;(4):CD004514. Review. Update in: Cochrane Database Syst Rev. 2008;(4):CD004514.

PMID:
14584018
15.

The menopause and HRT. HRT and cognitive decline.

Maki P, Hogervorst E.

Best Pract Res Clin Endocrinol Metab. 2003 Mar;17(1):105-22. Review.

PMID:
12763515
16.

Short and long term effects of tibolone in postmenopausal women.

Formoso G, Perrone E, Maltoni S, Balduzzi S, D'Amico R, Bassi C, Basevi V, Marata AM, Magrini N, Maestri E.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008536. doi: 10.1002/14651858.CD008536.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Oct 12;10 :CD008536.

PMID:
22336846
17.

Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?

Roy JA, Sawka CA, Pritchard KI.

J Clin Oncol. 1996 Mar;14(3):997-1006. Review.

PMID:
8622051
18.

Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.

Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black DM, Budoff MJ, Hodis HN, Naftolin F, Harman SM, Asthana S.

PLoS Med. 2015 Jun 2;12(6):e1001833; discussion e1001833. doi: 10.1371/journal.pmed.1001833. eCollection 2015 Jun.

19.

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

JAMA. 2003 May 28;289(20):2663-72.

PMID:
12771113
20.

Exercise for vasomotor menopausal symptoms.

Daley A, Stokes-Lampard H, Macarthur C.

Cochrane Database Syst Rev. 2011 May 11;(5):CD006108. doi: 10.1002/14651858.CD006108.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;11:CD006108.

PMID:
21563149

Supplemental Content

Support Center